일회용 내시경 회수 백 시장 : 시장 예측(2026-2032년)

The Disposable Endoscope Retrieval Bag Market is projected to grow by USD 352.49 million at a CAGR of 9.50% by 2032.

Disposable Endoscope Retrieval Bags: Executive Overview

Disposable endoscope retrieval bags are single-use accessories designed to contain and remove excised tissue, stones, foreign bodies, or other specimens during minimally invasive endoscopic procedures. Their clinical value is linked to specimen containment, procedural control, infection-prevention practices, and compatibility with endoscopic workflows. Adoption is shaped by procedure volumes, hospital purchasing standards, regulatory requirements, operating-room efficiency, and clinician confidence in deployment and retrieval performance.

How Containment, Safety, and Workflow Priorities Are Reshaping the Market

The landscape is shifting toward products that combine reliable deployment, secure closure, low-profile delivery, and intuitive retrieval. Healthcare providers increasingly evaluate disposable devices not only on unit price but also on their contribution to standardized sterile workflows, reduced reprocessing requirements, and predictable procedural performance. Environmental scrutiny is also encouraging attention to material selection, packaging reduction, waste segregation, and transparent lifecycle information without compromising infection-control requirements.

Procurement decisions are becoming more evidence-oriented. Hospitals and ambulatory centers are placing greater emphasis on documented usability, compatibility with existing endoscopes, clinician training, supply continuity, and clear instructions for use. Vendors and healthcare organizations must therefore balance clinical functionality, operational simplicity, regulatory compliance, and responsible disposal practices.

Artificial Intelligence Is Strengthening Procedure Planning and Quality Control

Artificial intelligence is influencing this market indirectly through broader advances in endoscopic imaging, lesion detection, procedure documentation, and workflow analytics. Better identification and characterization of findings can increase the need for dependable specimen-retrieval workflows, while procedure data can help teams assess deployment success, retrieval time, and device-related interruptions.

AI can also support inventory planning, demand sensing, training personalization, and post-market surveillance when data are appropriately governed. However, disposable retrieval bags remain physical devices whose safety depends on material integrity, mechanical performance, clinician judgment, and validated instructions. AI should therefore complement-not replace-clinical protocols, human oversight, cybersecurity controls, and regulatory evidence.

Regional Priorities Differ Across North America, Europe, and Growth Markets

North America generally emphasizes hospital quality systems, procedural efficiency, device traceability, and purchasing standardization. Europe places strong weight on regulatory conformity, clinical safety, sustainability expectations, and harmonized procurement considerations across the European Union. Asia-Pacific combines advanced procedural capabilities in established healthcare systems with expanding access and infrastructure development across diverse markets.

Latin America is influenced by public-sector procurement, private hospital investment, import conditions, and uneven access to specialized endoscopy. The Middle East shows demand linked to tertiary-care expansion, medical tourism, and centralized purchasing in several systems. Africa presents highly varied readiness, with opportunities tied to specialist-center development, training, reliable distribution, and cost-conscious single-use solutions. Across all regions, local regulatory pathways and supply-chain resilience remain decisive.

ASEAN, BRICS, EU, G7, GCC, and NATO Groups Reveal Distinct Operating Contexts

ASEAN markets reflect diverse healthcare maturity, import frameworks, and private-provider participation, making distributor capability and clinician education important. BRICS countries combine substantial patient populations and manufacturing potential with varied reimbursement, regulatory, and procurement environments. The European Union benefits from regulatory coordination and cross-border standards while retaining national differences in purchasing and clinical practice.

G7 healthcare systems typically apply rigorous evidence, quality, and infection-control expectations, with strong interest in workflow optimization. GCC markets often feature centralized procurement, advanced hospitals, and investment in specialist care, while local representation can be strategically important. NATO members are not a uniform healthcare bloc, but many share emphasis on supply resilience, continuity planning, and high standards for medical-device quality and institutional preparedness.

Country-Level Conditions Shape Adoption, Compliance, and Distribution

Australia and Canada combine structured healthcare procurement with geographically dispersed service delivery, increasing the importance of reliable distribution and training. Brazil, Mexico, Russia, India, and China present large and varied healthcare systems where public purchasing, domestic regulation, local manufacturing, and regional access can materially affect deployment. Japan and South Korea emphasize advanced endoscopy, quality assurance, and procedural precision.

France, Germany, Italy, Spain, and the United Kingdom operate within mature clinical and regulatory environments, but procurement structures and reimbursement conditions differ. The United States places strong emphasis on hospital protocols, supply continuity, and documented device performance. Across these countries, successful adoption depends on regulatory authorization, clinician familiarity, compatibility testing, distributor support, and evidence that the device improves procedural consistency without creating additional handling burden.

Prioritize Evidence, Compatibility, Resilience, and Responsible Use

Industry leaders should build product strategies around validated deployment and retrieval performance, clear compatibility specifications, ergonomic training, and evidence from relevant clinical workflows. Regulatory documentation should be maintained for each target jurisdiction, with post-market monitoring designed to capture device integrity, retrieval outcomes, adverse events, and user feedback.

Commercial and operational teams should diversify qualified suppliers, maintain critical inventory safeguards, and develop region-specific distribution and education plans. Hospitals should evaluate total workflow impact rather than price alone, including staff time, reprocessing avoidance, specimen containment, waste handling, and procedural interruptions. Environmental objectives should focus on measurable packaging and material improvements that preserve sterility and patient safety.

Methodology: Evidence-Based Synthesis of Clinical, Regulatory, and Operational Factors

This executive summary uses a qualitative market-analysis framework focused on the role of disposable endoscope retrieval bags in minimally invasive endoscopic care. The assessment synthesizes established considerations in device function, infection prevention, procurement, clinical workflow, regulation, healthcare infrastructure, distribution, sustainability, and digital transformation.

Regional, group, and country comparisons are framed as contextual insights rather than quantitative rankings. No market estimates, market shares, forecasts, or company-specific claims are used. Interpretations should be validated against current national regulations, institutional protocols, peer-reviewed clinical evidence, procurement requirements, and verified post-market safety information before making investment or product decisions.

Reliable Containment and Workflow Fit Will Define Sustainable Adoption

Disposable endoscope retrieval bags occupy a focused but clinically meaningful role in minimally invasive procedures. Their value rests on secure specimen containment, dependable handling, infection-control alignment, and seamless integration with endoscopic technique. Market progress will depend less on novelty alone than on demonstrable performance, regulatory discipline, training, supply reliability, and responsible lifecycle management.

Leaders that combine clinically relevant evidence with regional adaptation, interoperable design, resilient distribution, and transparent quality practices will be better positioned to support providers and patients. Continued attention to usability, data governance, sustainability, and real-world outcomes should guide future innovation and procurement decisions.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Definition
• 1.3. Market Segmentation & Coverage
• 1.4. Years Considered for the Study
• 1.5. Currency Considered for the Study
• 1.6. Language Considered for the Study
• 1.7. Key Stakeholders

2. Research Methodology

• 2.1. Introduction
• 2.2. Research Design
  • 2.2.1. Primary Research
  • 2.2.2. Secondary Research
• 2.3. Research Framework
  • 2.3.1. Qualitative Analysis
  • 2.3.2. Quantitative Analysis
• 2.4. Market Size Estimation
  • 2.4.1. Top-Down Approach
  • 2.4.2. Bottom-Up Approach
• 2.5. Data Triangulation
• 2.6. Research Outcomes
• 2.7. Research Assumptions
• 2.8. Research Limitations

3. Executive Summary

• 3.1. Introduction
• 3.2. CXO Perspective
• 3.3. New Revenue Opportunities
• 3.4. Next-Generation Business Models
• 3.5. Industry Roadmap

4. Market Overview

• 4.1. Introduction
• 4.2. Industry Ecosystem & Value Chain Analysis
  • 4.2.1. Supply-Side Analysis
  • 4.2.2. Demand-Side Analysis
  • 4.2.3. Stakeholder Analysis
• 4.3. Market Dynamics
  • 4.3.1. Key Drivers
  • 4.3.2. Key Restraints
  • 4.3.3. Key Opportunities
  • 4.3.4. Key Challenges
• 4.4. Porter's Five Forces Analysis
• 4.5. PESTLE Analysis
• 4.6. Market Outlook
  • 4.6.1. Near-Term Market Outlook (0-2 Years)
  • 4.6.2. Medium-Term Market Outlook (3-5 Years)
  • 4.6.3. Long-Term Market Outlook (5-10 Years)
• 4.7. Go-to-Market Strategy

5. Market Insights

• 5.1. Consumer Insights & End-User Perspective
• 5.2. Consumer Experience Benchmarking
• 5.3. Opportunity Mapping
• 5.4. Distribution Channel Analysis
• 5.5. Pricing Trend Analysis
• 5.6. Regulatory Compliance & Standards Framework
• 5.7. ESG & Sustainability Analysis
• 5.8. Disruption & Risk Scenarios
• 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Disposable Endoscope Retrieval Bag Market, by Endoscope Type

• 7.1. Introduction
• 7.2. Flexible
• 7.3. Rigid

8. Disposable Endoscope Retrieval Bag Market, by Material

• 8.1. Introduction
• 8.2. Composite
• 8.3. Non-Woven Fabric
• 8.4. Plastic

9. Disposable Endoscope Retrieval Bag Market, by Application

• 9.1. Introduction
• 9.2. Gastrointestinal
• 9.3. Pulmonary
• 9.4. Urological

10. Disposable Endoscope Retrieval Bag Market, by End User

• 10.1. Introduction
• 10.2. Ambulatory Surgical Centers
• 10.3. Clinics
• 10.4. Diagnostic Centers
• 10.5. Hospitals

11. Disposable Endoscope Retrieval Bag Market, by Distribution Channel

• 11.1. Introduction
• 11.2. Direct Sales
• 11.3. Distributors
• 11.4. Online

12. Disposable Endoscope Retrieval Bag Market, by Region

• 12.1. Introduction
• 12.2. Asia-Pacific
• 12.3. North America
• 12.4. Latin America
• 12.5. Europe
• 12.6. Middle East
• 12.7. Africa

13. Disposable Endoscope Retrieval Bag Market, by Group

• 13.1. Introduction
• 13.2. ASEAN
• 13.3. GCC
• 13.4. European Union
• 13.5. BRICS
• 13.6. G7
• 13.7. NATO

14. Disposable Endoscope Retrieval Bag Market, by Country

• 14.1. Introduction
• 14.2. United States
• 14.3. Canada
• 14.4. Mexico
• 14.5. Brazil
• 14.6. United Kingdom
• 14.7. Germany
• 14.8. France
• 14.9. Russia
• 14.10. Italy
• 14.11. Spain
• 14.12. China
• 14.13. India
• 14.14. Japan
• 14.15. Australia
• 14.16. South Korea

15. Competitive Landscape

• 15.1. Market Share Analysis, 2025
• 15.2. Market Concentration Analysis, 2025
  • 15.2.1. Concentration Ratio (CR)
  • 15.2.2. Herfindahl Hirschman Index (HHI)
• 15.3. Recent Developments & Impact Analysis, 2025
• 15.4. Product Portfolio Analysis, 2025
• 15.5. Benchmarking Analysis, 2025

16. Company Profiles

• 16.1. B. Braun Melsungen AG
• 16.2. Boston Scientific Corporation
• 16.3. CONMED Corporation
• 16.4. Cook Medical LLC
• 16.5. CooperSurgical, Inc.
• 16.6. Fujifilm Holdings Corporation
• 16.7. Genicon, Inc.
• 16.8. Hangzhou Boer Medical Instrument Co., Ltd.
• 16.9. Hangzhou Kangji Medical Instrument Co., Ltd.
• 16.10. Jiangsu Fengh Medical Instruments
• 16.11. LaproSurge Ltd.
• 16.12. Medtronic plc
• 16.13. Olympus Corporation
• 16.14. Purple Surgical Ltd.
• 16.15. Richard Wolf GmbH
• 16.16. Schultz Medical
• 16.17. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
• 16.18. Smith & Nephew plc
• 16.19. Suzhou Microcure Medical Co., Ltd.
• 16.20. Teleflex Incorporated
• 16.21. Unimax Medical Co., Ltd.
• 16.22. Vernacare Group plc
• 16.23. Volkmann Medizintechnik GmbH
• 16.24. Zhejiang Geyi Medical Instrument Co., Ltd.

17. Key Experts